Catalyst Pharmaceuticals Inc(CPRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 18.1 | EPS (ttm) | 1.74 | Insider Own | 8.8% | Shs Outstand | 122.2M | Perf Week | - |
| Market Cap | 3.86B | Forward P/E | 13.9 | EPS next Y | 19.53% | Insider Trans | - | Shs Float | 111.7M | Perf Month | 0.29% |
| Enterprise Value | 3.10B | PEG | 0.9 | EPS next Q | 0.46 | Inst Own | 83.42% | Short Float | 7.03% | Perf Quarter | 21.4% |
| Income | 0.22B | P/S | 6.46 | EPS this Y | 12.8% | Inst Trans | - | Short Ratio | 2.97 | Perf Half Y | 30.5% |
| Sales | 0.60B | P/B | 3.8 | EPS next 5Y | 15.37% | ROA | 21.52% | Short Interest | 7.85M | Perf YTD | 34.92% |
| Book/sh | 8.29 | P/C | 5.1 | EPS past 3/5Y | 31.19% 19% | ROE | 24.5% | 52W High | -3.29% ($32.56) | Perf Year | 45.65% |
| Cash/sh | 6.17 | P/FCF | 18.52 | Sales past 3/5Y | 40.1% 37.68% | ROIC | 21.81% | 52W Low | 65.3% ($19.05) | Perf 3Y | 144.87% |
| Dividend Est. | - | EV/EBITDA | 10.13 | EPS Y/Y TTM | 9.67% | Gross Margin | 79.62% | Volatility(W/M) | 0.07% 0.11% | Perf 5Y | 485.32% |
| Dividend TTM | - | EV/Sales | 5.2 | Sales Y/Y TTM | 11.65% | Oper. Margin | 44.83% | ATR (14) | 0.08 | Perf 10Y | 4042.88% |
| Dividend Ex-Date | - | Quick Ratio | 6.84 | EPS Q/Q | 12.37% | Profit Margin | 37.08% | RSI (14) | 70.17 | Recom | 2.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.1 | Sales Q/Q | 5.63% | SMA20 | 0.16% ($31.44) | Beta | 0.75 | Target Price | $31.75 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/5/11 | SMA50 | 0.9% ($31.21) | Rel Volume | 0 | Prev Close | $31.49 |
| Employees | 182 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 5.26% -0.12% | SMA200 | 24.23% ($25.35) | Avg Volume(3M) | 2.64M | Price | $31.49 |
| IPO | 2006/11/8 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
💊 A U.S. biopharmaceutical company that sells treatments for rare diseases. It commercializes and sells therapies indicated for rare neuromuscular disorders and epilepsy, and is characterized by stable, profitable revenue and an expanding product portfolio. The company is a commercial-stage biopharmaceutical firm specializing in rare diseases.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
CPRX makes money exceptionally well
Of every $100 in sales, $44.83 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.8% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,390. Peers typically go for $2,616. It is about in line with its own 5-year average.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +485.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 83.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #62 of 595 in the industry
Based on market cap of $4B.
ARQT#61 Arcutis Biotherapeutics Inc $4B PER 154.4 CPRX#62 Catalyst Pharmaceuticals Inc $4B PER 18.1 
TNGX#62 Tango Therapeutics Inc $4B PER - 
TARS#63 Tarsus Pharmaceuticals Inc $4B PER - 
XENE#64 Xenon Pharmaceuticals Inc $4B PER - 
FAQ
What kind of company is CPRX?
CPRX belongs to the Healthcare sector and operates in the Biotechnology industry.
What is the market cap of CPRX?
The market cap of CPRX is approximately $3.9B, ranking 1,609 within its sector.
What is the P/E ratio of CPRX?
CPRX has a P/E ratio of approximately 18.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CPRX?
CPRX has recorded a 52-week high of $32.56 and a low of $19.05.
